Literature DB >> 30802323

Quality of life and disease severity in dermatitis patients with fragrance allergy-A cross-sectional European questionnaire study.

Niels H Bennike1, Maria S Heisterberg1, Ian R White2, Vera Mahler3,4, Juan F Silvestre-Salvador5, Ana Giménez-Arnau6, Jeanne D Johansen1.   

Abstract

BACKGROUND: Fragrance contact allergy is common, but few studies on quality of life (QoL) in affected patients exist. Recently, the disease-specific Fragrance Quality of Life Index (FQLI) was developed.
OBJECTIVES: To characterize QoL in European dermatitis patients with fragrance contact allergy at the time of diagnosis.
METHODS: This was a cross-sectional study, in which 2011 Danish, British, Spanish and German adult consecutive dermatitis patients were invited to complete a questionnaire on self-reported disease severity, the Dermatology Life Quality Index (DLQI), and the FQLI immediately prior to being patch tested.
RESULTS: One thousand seven hundred and fifty-eight patients responded, and 259 (14.7%; country range 11.7%-18.5%) were fragrance-positive. Among these, the total (SD) DLQI score was 6.2 (5.6) and the total (SD) FQLI score was 60 (25), with both estimates being comparable to those in fragrance-negative patients. Adjusting the total FQLI score for age, sex and self-rated disease severity showed a higher (ie, worse) score in fragrance-positive patients (3.6-point increase; 95% confidence interval: 0.30-6.8 points; P = 0.03). Specifically, contact allergy to oxidized linalool was associated with greater impairment in QoL.
CONCLUSIONS: QoL in patients with fragrance contact allergy is impaired at a level comparable to that in other patch tested dermatitis patients, at the time of diagnosis, across several European countries.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  European; allergic contact dermatitis; contact allergy; cross-sectional questionnaire; fragrance allergy; patch testing; patient-reported outcomes; quality of life

Year:  2019        PMID: 30802323     DOI: 10.1111/cod.13252

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  3 in total

Review 1.  Contact Allergy-Emerging Allergens and Public Health Impact.

Authors:  Wolfgang Uter; Thomas Werfel; Jean-Pierre Lepoittevin; Ian R White
Journal:  Int J Environ Res Public Health       Date:  2020-04-01       Impact factor: 3.390

Review 2.  Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder.

Authors:  Ester Di Agosta; Lorenzo Salvati; Monica Corazza; Ilaria Baiardini; Francesca Ambrogio; Luisa Angileri; Elettra Antonelli; Federica Belluzzo; Domenico Bonamonte; Laura Bonzano; Raffaele Brancaccio; Paolo Custurone; Aurora De Marco; Aikaterini Detoraki; Adriana Di Guida; Elisabetta Di Leo; Marta Fantò; Filippo Fassio; Silvia Mariel Ferrucci; Caterina Foti; Rosella Gallo; Alessia Gatta; Fabrizio Guarneri; Lucia Guidolin; Katharina Hansel; Donatella Lamacchia; Carla Lombardo; Paola Lucia Minciullo; Maddalena Napolitano; Alessandro Pannofino; Andrea Paravisi; Roberta Parente; Maria Passante; Cataldo Patruno; Diego Peroni; Cristina Quecchia; Natale Schettini; Giuseppe Spadaro; Luca Stingeni; Daniele Tarrini; Marta Tramontana; Eustachio Nettis; Oliviero Rossi
Journal:  Clin Mol Allergy       Date:  2021-12-20

3.  Simultaneous patch testing with fragrance markers in the baseline series and the ingredients of fragrance mixes: An update from southern Sweden.

Authors:  Thanisorn Sukakul; Magnus Bruze; Martin Mowitz; Annarita Antelmi; Waranya Boonchai; Jakob Dahlin; Nils Hamnerius; Inese Hauksson; Tina Lejding; Cecilia Svedman
Journal:  Contact Dermatitis       Date:  2022-03-03       Impact factor: 6.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.